Last reviewed · How we verify
Opioid-free Anesthesia-Analgesia Strategy — Competitive Intelligence Brief
marketed
Anesthesiology
Small molecule
Live · refreshed every 30 min
Target snapshot
Opioid-free Anesthesia-Analgesia Strategy (Opioid-free Anesthesia-Analgesia Strategy) — University of Crete. A multimodal anesthesia-analgesia strategy that avoids opioid medications by combining regional anesthesia, local anesthetics, and non-opioid analgesics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Opioid-free Anesthesia-Analgesia Strategy TARGET | Opioid-free Anesthesia-Analgesia Strategy | University of Crete | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Opioid-free Anesthesia-Analgesia Strategy CI watch — RSS
- Opioid-free Anesthesia-Analgesia Strategy CI watch — Atom
- Opioid-free Anesthesia-Analgesia Strategy CI watch — JSON
- Opioid-free Anesthesia-Analgesia Strategy alone — RSS
Cite this brief
Drug Landscape (2026). Opioid-free Anesthesia-Analgesia Strategy — Competitive Intelligence Brief. https://druglandscape.com/ci/opioid-free-anesthesia-analgesia-strategy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab